Sonomind is a medical device company specializing in non-invasive brain stimulation utilizing low-intensity focused ultrasound to treat drug-resistant conditions. The Paris-based biotech and life science startup develops novel neurostimulation therapies and recently secured funding to advance its medical technology.
Subscribe to see Sonomind’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sonomind is a therapeutic devices company headquartered in France. It has raised at least $27M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $23.5M in May 2026. Xcout tracks 6 named people at Sonomind, including Jeremy Bercoff (CEO).
At least $27M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $23.5M | 2 named | |
| Seed | $3.5M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.